Trial Profile
Efficacy and Safety of Aripiprazole in the Treatment of Acutely Relapsed Patients With Schizophrenia or Schizoaffective Disorder With Risperidone as an Active Control
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone
- Indications Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 05 Nov 2010 New trial record.